Ann: Final Preclinical Asthma Study Confirms Efficacy, page-33

I might be wrong here, but the faseb journal article
"Intranasal administration of mesenchymoangioblast-derived mesenchymal stem cells abrogates airway fibrosis and airway hyperresponsiveness associated with chronic allergic airways disease"
says abrogate.
http://m.fasebj.org/content/early/2...ract?sid=8752bcf8-c83b-48b9-8c3e-c41829458924

Another article referring to the faseb article above is saying reversed:
"IN delivery of Cymerus™ MSCs completely reversed pathologic collagen deposition in the lungs to levels seen in animals in which the asthma model was not induced. Pathologic collagen deposition is a sign of airway remodelling/fibrosis. Previous studies by the same group found that IN administration of other types of stem cells did not have similar effects, unless used in combination with other drugs"
https://www.biospace.com/article/re...-published-in-leading-peer-reviewed-journal-/

Somehow that's quite different to the way you are reading it. How come?